Pfizer Makes Great Portfolio Medication

So today I bought 4,011 shares of Pfizer (PFE) at market price, and the transaction went through at $24.91 per share. The Wrigley's (WWY) transaction that I had put through after market close yesterday went through at $68.0 per share. So currently I have positions of $100,224.60 in Wrigley's, and $99,673.35 in Pfizer. This leaves a current virtual portfolio equity value of $1,000,056.13. The Stock-Trak virtual portfolio platform allows an account to have twice the buying power of its original cash value. What I'll probably do is buy up 10 equity positions to aim to hold for the full 10-week analysis period, and use the margin buying power for shorter term swing trades and speculative investing.

Pfizer - Thoughts, Analysis and News:

Pfizer had previously been discussed briefly in both the Six Stocks for 2006 post, and the post on the 2005 Dogs of the Dow. I mentioned that Pfizer had a high dividend yield ratio of 3.90% which is promising, but also a higher price/earnings ratio of currently 22.65. However, when averaged with Pfizer's forward p/e of 12.24, we come up with an averaged (forward p/e + trailing p/e)/2 = of 17.4, which suddenly makes Pfizer seem more attractive even after today's jump up of 1.10%.

newratings.com: "Analyst John Boris of Bear Stearns reiterates his "outperform" rating on Pfizer Inc. The target price is set to $30."

Dow Jones: "Pfizer Inc. has begun to ship Viagra as its first product in the U.S. containing counterfeit deterrent radio frequency identification tags on drug packaging."

Yahoo! Finance: "The internal race to succeed Pfizer Inc. Chief Executive Henry McKinnell has created "some tension," he said, but investors should be reassured that the drug giant has three or four strong internal candidates for the top spot."